Research and Development Expense (TTM) Chart

Historical Research and Development Expense (TTM) Data

View and export this data back to 2021. Start Trial.
Date Value
September 30, 2026 43.60M
June 30, 2026 41.83M
March 31, 2026 38.72M
December 31, 2025 46.71M
September 30, 2025 38.93M
June 30, 2025 33.38M
March 31, 2025 27.85M
December 31, 2024 11.61M
September 30, 2024 8.782M
June 30, 2024 8.14M
March 31, 2024 10.78M
December 31, 2023 15.41M
Date Value
September 30, 2023 17.21M
June 30, 2023 18.59M
March 31, 2023 23.67M
December 31, 2022 26.21M
September 30, 2022 28.17M
June 30, 2022 29.90M
March 31, 2022 26.92M
December 31, 2021 23.32M
September 30, 2021 18.39M
June 30, 2021 13.76M
March 31, 2021 9.591M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Korsana Biosciences, Inc. 43.39M
Cullinan Therapeutics, Inc. 169.67M
Q32 Bio, Inc. 15.94M
Oncolytics Biotech, Inc. 13.18M
Sangamo Therapeutics, Inc. 113.79M